180 Life Sciences Extends Rally After Revealing $349 Million Ethereum Reserve
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 13 2025
0mins
Source: Benzinga
Company's Financial Strategy: 180 Life Sciences Corp. has increased its holdings to over $349 million in Ethereum (ETH) as part of a new treasury strategy, planning to rebrand as ETHZilla Corporation and implement an on-chain yield generation program.
Stock Performance: Following a significant private offering, shares of 180 Life Sciences surged by 32.52%, trading at $13.57, reflecting a substantial increase compared to its moving averages and previous trading levels.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.





